Synergistic Molecular Strategies for Targeting the Unfolded Protein Response in Cancer Therapy

Area of Science:

• Oncology
• Molecular Biology
• Cellular Stress Response

Background:

• The Unfolded Protein Response (UPR) is crucial for maintaining cellular homeostasis, particularly in cancer cells with high secretory activity.
• Cancer cells often exhibit hyperactivated UPR, making them dependent on this pathway for survival and vulnerable to endoplasmic reticulum (ER) stress.
• Targeted therapies can modulate cellular pathways, including the UPR, offering new avenues for cancer treatment.

Purpose of the Study:

• To establish a mechanistic framework for classifying synergistic cancer therapies based on their impact on ER stress and UPR activation.
• To explore how different synergistic strategies influence the UPR's pro-survival and pro-apoptotic functions.
• To identify therapeutic approaches that exploit cancer cell vulnerability to proteotoxic stress.

Main Methods:

• Classification of synergistic therapies by their mechanisms of action, focusing on UPR modulation.
• Analysis of agents targeting UPR feedback loops (e.g., GRP78 antagonists).
• Investigation of inhibitors targeting key UPR branches (PERK, IRE1α) and indirect modulators (TKIs, BTK inhibitors).

Main Results:

• Synergistic therapies can be categorized by their specific interactions with the ER stress and UPR pathways.
• Pharmacologic agents can shift the UPR from a pro-survival to a pro-apoptotic state.
• Combinations of therapies can exacerbate proteotoxic stress in cancer cells.

Conclusions:

• Synergistic combinations of targeted therapies hold promise for overcoming therapeutic resistance in cancer.
• These combinations can selectively induce apoptosis in cancer cells with high proteotoxic stress.
• Targeting the UPR and ER stress represents a promising strategy in oncology.